← Leaderboards
Deborah Krakow
Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center
$5,601,232
Attributed
$7,389,332
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2006–24$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$7,389,332 · 7
By mechanism
R01$3,605,221 · 2
P01$2,101,710 · 1
T32$1,651,201 · 1
M01$31,200 · 3
Top collaborators
- Daniel H Cohn5 shared
- Mark S. Litwin5 shared
Others in their field
Top investigators on “Genes”
- David Heimbrook · Leidos Biomedical Research, Inc.$413,811,031
- Richard A Gibbs · Baylor College Of Medicine$338,750,128
- Barton F Haynes · Duke University$304,076,400
- Stacey Gabriel · Massachusetts Institute Of Technology$241,252,013
- Eric S Lander · Whitehead Institute For Biomedical Res$211,825,987
- Richard K. Wilson · Washington University$195,881,965
Research focus
GenesDefectSkeletonPhenotypeInsightLeadResourcesPathway InteractionsBoneFamilyBiologyInternationalMolecularGenetic CounselingGeneticGrowthMutationComplementGene DiscoveryAffectBiologicalCell LineComplexRegistries
Grant awards (23)
Patient-Centered Outcomes Research Training in Urologic and Gynecologic Cancers (PCORT UroGynCan)$298,621
T32 · FY2024 · CA
Patient-Centered Outcomes Research Training in Urologic and Gynecologic Cancers (PCORT UroGynCan)$375,344
T32 · FY2023 · CA
Patient-Centered Outcomes Research Training in Urologic and Gynecologic Cancers (PCORT UroGynCan)$179,636
T32 · FY2022 · CA
Patient-Centered Outcomes Research Training in Urologic and Gynecologic Cancers (PCORT UroGynCan)$401,573
T32 · FY2021 · CA
Project 2: The role of the HSP47/FKBP65 chaperone complex in osteogenesis imperfecta$417,417
P01 · FY2020 · HD · contact PI
Patient-Centered Outcomes Research Training in Urologic and Gynecologic Cancers (PCORT UroGynCan)$396,027
T32 · FY2020 · CA
Project 2: The role of the HSP47/FKBP65 chaperone complex in osteogenesis imperfecta$417,417
P01 · FY2019 · HD · contact PI
Short-rib polydactyly and the skeletal ciliopathies$385,000
R01 · FY2019 · DE
Project 2: The role of the HSP47/FKBP65 chaperone complex in osteogenesis imperfecta$417,417
P01 · FY2018 · HD · contact PI
Short-rib polydactyly and the skeletal ciliopathies$385,000
R01 · FY2018 · DE
Unraveling the mechanisms of prenatal-onset disorders affecting the skeleton$333,074
R01 · FY2018 · AR · contact PI
Project 2: The role of the HSP47/FKBP65 chaperone complex in osteogenesis imperfecta$417,417
P01 · FY2017 · HD · contact PI
Short-rib polydactyly and the skeletal ciliopathies$385,000
R01 · FY2017 · DE
Unraveling the mechanisms of prenatal-onset disorders affecting the skeleton$333,383
R01 · FY2017 · AR · contact PI
Project 2: The role of the HSP47/FKBP65 chaperone complex in osteogenesis imperfecta$432,042
P01 · FY2016 · HD · contact PI
Short-rib polydactyly and the skeletal ciliopathies$385,000
R01 · FY2016 · DE
Unraveling the mechanisms of prenatal-onset disorders affecting the skeleton$333,680
R01 · FY2016 · AR · contact PI
Short-rib polydactyly and the skeletal ciliopathies$385,000
R01 · FY2015 · DE
Unraveling the mechanisms of prenatal-onset disorders affecting the skeleton$333,965
R01 · FY2015 · AR · contact PI
Unraveling the mechanisms of prenatal-onset disorders affecting the skeleton$346,119
R01 · FY2014 · AR · contact PI
THE SKELETAL DYSPLASIAS (PROJECT 2)$4,655
M01 · FY2009 · RR · contact PI
ASPERGILLLUS ANGIONVASION AND DISSEMINATION$6,911
M01 · FY2007 · RR · contact PI
ASPERGILLLUS ANGIONVASION AND DISSEMINATION$19,634
M01 · FY2006 · RR · contact PI